About PharmaNovia
PharmaNovia is a Healthcare company based in Copenhagen (Denmark) founded in 2003, and was acquired by Triton Partners in August 2019. Generic oncology products and antibiotics are manufactured in Copenhagen. The company has 57 employees. PharmaNovia has completed 1 acquisition, including Lamepro. Its Indian entity Pharmanovia India Private Limited reported revenue of βΉ30.65 Cr. Its focus areas include Traditional Pharmaceuticals, Generics, Therapeutic Areas and Oncology.
Company details
PharmaNovia was founded in 2003 in Copenhagen, Denmark, and operates as a manufacturer of generic pharmaceuticals. Focus is placed on oncology products, with additional lines in antibiotics and antidotes for heavy metal poisoning. The company, previously known as NordMedica, produces these generics for therapeutic applications. Operations are centered in the pharmaceutical sector, serving global markets from its Danish base.
- Headquarters Copenhagen, Denmark
- Employees 57
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phoneβ’β’β’β’ β’β’β’β’
- Website pharmanovia.com
- Social LinkedIn
- Acquired by Triton Partners (Aug 2019)
- Legal Name Pharmanovia India Private Limited
- Date of Incorporation 27 Jun, 2020
- Jurisdiction Vadodara, Gujarat, India
- Indian entity revenue₹30.65 Cr
FY 2025 · +28% YoY
- Indian entity net profit₹3.69 Cr
FY 2025 · 12% margin
- Indian entity EBITDA₹7.01 Cr
FY 2025 · 23% margin
- Investors
- Employee Count57
- Investments & Acquisitions
- Acquired byTriton Partners
(Aug 2019)
Associated legal entities of PharmaNovia
PharmaNovia operates through Pharmanovia India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pharmanovia India Private Limited CIN U24304GJ2020FTC114194 | Active | 27 Jun 2020 | Vadodara, Gujarat | ₹30.7 Cr | 57 | 5 | View details |
Investors in PharmaNovia
PharmaNovia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Triton Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt fund focused on service, healthcare, consumer, and industrial sectors | 1997 | triton-partners.com | London, United Kingdom |
Investor details for PharmaNovia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Pharmanovia India Private Limited (PharmaNovia)
Pharmanovia India Private Limited is the primary company behind PharmaNovia. The board of Pharmanovia India Private Limited currently have 4 directors; the longest-serving is Gurusubramanian Gopalan, appointed in 2020. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gurusubramanian Gopalan DIN 07774380 | Director | 27 Jun 2020 | 6 yrs 4 mo | Pharmanovia India Private Limited |
| Amit Vijaykumar Patel DIN 08884701 | Director | 21 Sep 2020 | 6 yrs 2 mo | Pharmanovia India Private Limited |
| Muzammil Ali Jasnaik DIN 11116403 | Additional Director | 20 May 2025 | 1 yr 6 mo | Pharmanovia India Private Limited |
| Tarunkumar Satpathy DIN 11205772 | Additional Director | 22 Jul 2025 | 1 yr 4 mo | Pharmanovia India Private Limited |
People of PharmaNovia
19 people are tracked at PharmaNovia (9 in leadership, 10 in team); the tracked headcount is 57.
| Name | Role | Group |
|---|---|---|
Steve Deacon | Chief Scientific Officer | Leadership |
Alison Dyson | Director Of Communications | Leadership |
Dr. James Burt | Chief Executive Officer | Leadership |
Shiraz Omar | Chief Integration And Procurement Officer | Leadership |
Chris Evans | Director, Quality Operations | Leadership |
Hashim Hashim | Vice President Of Product Development | Leadership |
Suresh Jassel | A Vice President Quality & Pharmacovigilance | Leadership |
James Lee | Chief Brand Officer | Leadership |
Martin S. | Vice President, Global Head Of Strategic Marketing & Commercial Excellence | Leadership |
Chirayu Olkar | Senior Executive, Supply Chain | Team |
Roshan Rathnasekara | Supply Chain Senior Manager - External Manufacturing | Team |
Apitha Sugumar | Supply Chain Logistics And Customs Senior Manager | Team |
Rebekah Zachej | Global Brand Manager Endocrinology | Team |
Parvez Ghodiwala | Senior Supply Chain Manager | Team |
Vibeke Bro Pedersen | Global Brand Manager, Oncology | Team |
Angelique E. | Quality And Technical Manager | Team |
Mahmoud Alghanim | Key Account Manager | Team |
Sriram Pathmarajah | Associate Manager, Global Procurement | Team |
Claire S. | Senior Manager- Supply Chain Support | Team |
Complete people profiles for PharmaNovia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PharmaNovia
Figures of Pharmanovia India Private Limited, the primary company behind PharmaNovia, for FY 2025. Revenue was ₹30.65 Cr (+28% year on year). Net profit was ₹3.69 Cr (12% margin). EBITDA was ₹7.01 Cr (23% margin). Revenue has grown at a compounded annual rate of +41% over three years.
- ₹30.65 CrRevenue · FY 2025 · +28% YoY
- ₹3.69 CrNet profit · 12% margin
- ₹7.01 CrEBITDA · 23% margin
- ₹12.51 CrPaid-up capital
- 57Employees (provident fund records)
- +41%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Pharmanovia India Private Limited are on its company page.
Detailed financial statements for PharmaNovia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaNovia
PharmaNovia has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lamepro.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical products for multiple disease treatments are provided. | lamepro.nl | Netherlands | 0 | Mar 2022 | β’β’β’β’ |
Complete acquisition details for PharmaNovia
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PharmaNovia
3 dated milestones of PharmaNovia across 19 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaNovia is founded.
- Exit Acquired by Triton Partners.
- Acquisition Acquires Lamepro.
Web traffic of PharmaNovia
The website of PharmaNovia (pharmanovia.com) receives about 4.6K visits a month and ranks #3,910,190 among all websites worldwide, #4,955 in Biotechnology and Pharmaceuticals.
- Monthly visits4.6K
▼ 1.5% vs previous month
- Unique visitors2K
per month
- Global rank#3,910,190
among all websites
- Category rank#4,955
Health · Biotechnology and Pharmaceuticals
- Bounce rate44%
- Pages per visit1.8
- Average visit25 sec
- DevicesDesktop 43% Β· Mobile 57%
Websites whose visitors overlap most with PharmaNovia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmaphorum.com | 100% | 128.2K | #451,885 | View details | |
| pmcpa.org.uk | 100% | #2,335,332 | View details | ||
| parkinsons.org.uk | 60% | #163,700 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmanovia
Complete news archive for PharmaNovia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaNovia
PharmaNovia was founded in 2003.
PharmaNovia is headquartered in Copenhagen, Denmark.
PharmaNovia has 57 employees.
The primary company behind PharmaNovia, Pharmanovia India Private Limited, reported revenue of βΉ30.65 Cr for FY 2025, up 28% year on year.
PharmaNovia was founded in 2003 in Copenhagen, Denmark, and operates as a manufacturer of generic pharmaceuticals. Focus is placed on oncology products, with additional lines in antibiotics and antidotes for heavy metal poisoning. The company, previously known as NordMedica, produces these generics for therapeutic applications. Operations are centered in the pharmaceutical sector, serving global markets from its Danish base.
PharmaNovia has made 1 acquisition, including Lamepro.
PharmaNovia has 1 investor. Key investors include Triton Partners.
PharmaNovia operates through Pharmanovia India Private Limited.
Yes. PharmaNovia was acquired by Triton Partners in August 2019.
The legal entities of PharmaNovia currently have 5 directors, including Nidhi Nidhish Shah, Amit Vijaykumar Patel, Gurusubramanian Gopalan and others.

